Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,160,953
-
Share change
-
-3,293,400
-
Total reported value
-
$33,146,923
-
Put/Call ratio
-
862%
-
Price per share
-
$2.97
-
Number of holders
-
35
-
Value change
-
-$12,477,568
-
Number of buys
-
9
-
Number of sells
-
23
Institutional Holders of InflaRx N.V. - COM (IFRX) as of Q2 2021
As of 30 Jun 2021 InflaRx N.V. - COM (IFRX) had 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,160,953 shares of stock of the company.
Largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, GREAT POINT PARTNERS LLC, ORBIMED ADVISORS LLC, MORGAN STANLEY, Ikarian Capital, LLC, DAFNA Capital Management LLC, Laurion Capital Management LP, KINGDON CAPITAL MANAGEMENT, L.L.C., FNY Investment Advisers, LLC, and Bank Julius Baer & Co. Ltd, Zurich.
This table shows 35 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.